The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2022 | Increasing access to blood transfusions during hospice care & implementing palliative care in AML
Mark Litzow, MD, Mayo Clinic, Rochester, MN, comments on the key recommendations that emerged from a session at ASH that aimed to develop guidelines for the treatment of older adults with acute myeloid leukemia (AML), including the need to improve access to blood transfusions during hospice care and to implement palliative care early on in the treatment of patients with AML and other advanced hematological malignancies. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Amgen: Research Funding; Astellas: Research Funding; Novartis: Research Funding; Syndax: Research Funding; Jazz: Consultancy, Membership on an entity’s Board of Directors or advisory committees; Actinium: Research Funding; Pluristem: Research Funding; Biosight: Consultancy, Other: Data Monitoring Board; Abbvie: Research Funding.
